Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,189
datasets available to search
ShareScore release 0.9.0
Dataset results
2,189 results for “AML”
Daunorubicin or Idarubicin With Cytarabine Plus Quizartinib vs Physician's Choice in Newly Diagnosed FLT3-ITD+ AML
ClinicalTrials.gov study NCT04676243. IPD Sharing: NO. Countries: 0. Publications: 0.
Safety and Pharmacokinetics of Oral F901318 (Fluconazole and Posaconazole) IN Aml Leukaemia
ClinicalTrials.gov study NCT03036046. IPD Sharing: NO. Countries: 0. Publications: 0.
Clinical Study of Novel CAR-ITNK Cells Targeting CD70 and CLL1 for Refractory/Relapsed AML
ClinicalTrials.gov study NCT07336875. IPD Sharing: NO. Countries: 0. Publications: 0.
Mitoxantrone Hydrochloride Liposome Combined With BU/Cy Were Used as a Conditioning Regimen for Patients With Intermediate/Adverse Risk or Persistently Positive MRD AML
ClinicalTrials.gov study NCT06758726. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Multi-antigen Specific CD8+ T Cells With Decitabine and Lymphodepleting Chemotherapy for the Treatment of Patients With Relapsed or Refractory AML or MDS Following an Allogeneic Hematopoietic Cell Tra
ClinicalTrials.gov study NCT06572631. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Cytokine-induced Memory-like NK Cells in Combination With Chemotherapy in Pediatric Patents With Refractory or Relapsed AML
ClinicalTrials.gov study NCT04354025. IPD Sharing: NO. Countries: 0. Publications: 0.
Daunorubicin, Cytarabine Liposomes Plus Venetoclax vs Azacitidine Plus Venetoclax in AML Patients Unfit for Intensive Chemotherapy
ClinicalTrials.gov study NCT06770257. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Magrolimab Plus Intensive Chemotherapy in Newly Diagnosed AML or HR-MDS
ClinicalTrials.gov study NCT05829434. IPD Sharing: NO. Countries: 0. Publications: 0.
Efficacy and Safety of MTBF Conditioning Regimen for Salvageable Allo-HSCT in the Treatment of R/R AML
ClinicalTrials.gov study NCT06385808. IPD Sharing: Not stated. Countries: 0. Publications: 0.
DEC-C and Thioguanine for R/R AML
ClinicalTrials.gov study NCT06351306. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Dose-Escalation Study of Ponatinib, a FLT3 Inhibitor, With and Without Combination of 5-Azacytidine, in Patients With FLT3-Mutated Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT02829840. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Venetoclax, Azacitidine, and Lintuzumab-Ac225 in AML Patients
ClinicalTrials.gov study NCT03932318. IPD Sharing: Not stated. Countries: 0. Publications: 0.
ELU001 in Pediatric Subjects Who Have Relapsed and/or Refractory CBFA2T3-GLIS2-positive AML
ClinicalTrials.gov study NCT05622591. IPD Sharing: NO. Countries: 0. Publications: 0.
B7.1/IL-2 Leukaemia Cell Vaccine for Non-Transplant AML RFUSIN2-AML2 (NTX)
ClinicalTrials.gov study NCT02493829. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Implantation of an Advanced Practice Nurse in the Complex Care Pathway of Patients With AML
ClinicalTrials.gov study NCT05309018. IPD Sharing: Not stated. Countries: 0. Publications: 0.
γδ T Cell Therapy for Relapse Prevention in High-Risk AML Post-Transplant
ClinicalTrials.gov study NCT07123662. IPD Sharing: Not stated. Countries: 0. Publications: 0.
ACHIEVE2 - Safety and Preliminary Efficacy of Intravenous TCB008 in Patients With Relapse or Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)/AML
ClinicalTrials.gov study NCT06463327. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.
Study of APVO436 in Elderly or Unfit Patients With Newly Diagnosed AML
ClinicalTrials.gov study NCT04973618. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Aezea® (Cenersen) and Chemotherapy for AML Subjects ≥ 55 Years of Age With No Response to Frontline Induction Course
ClinicalTrials.gov study NCT00967512. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Cytokine-induced Memory-like NK Cells in Relapsed/Refractory AML and MDS
ClinicalTrials.gov study NCT04893915. IPD Sharing: NO. Countries: 0. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.